Beurs.nl monitor iconMarkt Monitor
  • AEX -7,48 953,58 -0,78%
  • DE40 0,00 23.734,02 0,00%
  • US500^ -8,83 6.714,03 -0,13%
  • US30^ -75,50 46.860,30 -0,16%
  • EUR/USD +0,00 1,1560 +0,13%
  • WTI +0,56 60,02 +0,94%
  • Gold spot +21,55 4.002,86 +0,54%

Ebusco 2025

8.098 Posts
Pagina: «« 1 ... 337 338 339 340 341 ... 405 »» | Laatste | Omlaag ↓
  1. forum rang 7 Bye 18 augustus 2025 13:05
    quote:

    Lekker Truitje schreef op 18 augustus 2025 11:53:

    @ Blik dekkende afbijt :
    was het niet zo dat de bussen op zich in China worden gemaakt, maar dat klanten op verzoek bepaalde details kunnen laten invullen en dat dat dan door Ebusco kan worden gedaan ? Niet alle afgeleverde bussen zijn allemaal exact het zelfde en moeten vaak voldoen aan klantenspecificaties.
    Bij Ebusco is alles mogelijk.
  2. forum rang 7 Bye 18 augustus 2025 15:34
    quote:

    DeZwarteRidder schreef op 18 augustus 2025 14:50:

    [...]

    Alles behalve een happy end.....
    Voor dit prachtige bedrijf geldt een beleggingshorizon van 30 jaar.
  3. forum rang 7 Wilbar 18 augustus 2025 17:27
    quote:

    DeZwarteRidder schreef op 18 augustus 2025 14:50:

    [...]

    Alles behalve een happy end.....
    U schijnt te weten wat dat inhoudt?
  4. forum rang 6 BtB180 18 augustus 2025 20:53
    quote:

    Brummus94 schreef op 18 augustus 2025 19:33:

    Positief, staan er beter voor dan drie maanden geleden
    U bent een rasoptimist.
  5. Pter 18 augustus 2025 21:13
    quote:

    Brummus94 schreef op 18 augustus 2025 19:33:

    Positief, staan er beter voor dan drie maanden geleden
    Het stukje ervoor had je ook gelezen?

    Ook bleek dat een faillissement nog altijd dreigt voor Ebusco als er geen extra investeringen worden gevonden. Het bedrijf heeft „een aanzienlijke liquiditeitsinjectie nodig om haar continuïteit” als financieel gezonde onderneming „te kunnen waarborgen”. Ebusco is met leveranciers in gesprek over een regeling omdat het momenteel niet alle schulden kan betalen.
  6. forum rang 6 Ruval 18 augustus 2025 21:18
    Werkelijk stuitend hoe positief Bijvelds nog durft te zijn. “We hebben het beste product”. Ja, maar dan moet je ze wel kunnen produceren.

    Dese man is er mede verantwoordelijk voor dat veel beleggers bakken met geld hebben verloren. Mede op basis van zijn luchtfietserij, waan ideeën en een leugenachtig prospectus
  7. TraderT123 18 augustus 2025 22:25
    Als ik sommige mensen op dit forum had moeten geloven was Ebusco al 10 keer failliet gegaan in het afgelopen jaar.

    Ebusco 2.0 is vandaag officieel van start gegaan.

    38 cent is een koopie.
  8. forum rang 6 Ruval 18 augustus 2025 22:59
    quote:

    TraderT123 schreef op 18 augustus 2025 22:25:

    Als ik sommige mensen op dit forum had moeten geloven was Ebusco al 10 keer failliet gegaan in het afgelopen jaar.

    Ebusco 2.0 is vandaag officieel van start gegaan.

    38 cent is een koopie.
    Die eerste zin is wel heel vreemd. Dat is toch een feit? En volgens mij zijn er nog steeds acute liquiditeits problemen…

    Graag even de onderbouwing waarom huidige koers een ‘koopje’ is en stop anders met posten van dit soort rare berichten
  9. Pter 18 augustus 2025 23:31
    quote:

    TraderT123 schreef op 18 augustus 2025 22:25:

    Als ik sommige mensen op dit forum had moeten geloven was Ebusco al 10 keer failliet gegaan in het afgelopen jaar.

    Ebusco 2.0 is vandaag officieel van start gegaan.

    38 cent is een koopie.
    Wat een onzin! De aankomende verwatering negeer je maar even volledig.
  10. forum rang 4 Financiator 18 augustus 2025 23:42
    quote:

    TraderT123 schreef op 18 augustus 2025 22:25:

    Als ik sommige mensen op dit forum had moeten geloven was Ebusco al 10 keer failliet gegaan in het afgelopen jaar.

    Ebusco 2.0 is vandaag officieel van start gegaan.

    38 cent is een koopie.
    Als je je geld nou gewoon in brand steekt dan heb je ten minste nog het plezier van een leuk vlammetje voordat het weg is, bij Ebusco is je geld direct weg...
  11. forum rang 4 Endless 19 augustus 2025 07:55
    View this mail online

    Ebusco issues new shares under loan conversions and publishes an information document
    Deurne, 19 August 2025 – Following the authorization granted by the shareholders in the Extraordinary General Meeting of Ebusco Holding N.V. (‘Ebusco’ or the ‘Company’) (Euronext: EBUS) on 18 August 2025, Ebusco will now issue 99,587,859 new shares and has published an information document related to the admission to listing and trading of such shares.

    Following the Extraordinary General Meeting that took place yesterday, 18 August 2025 (the EGM), the Management Board of Ebusco Holding N.V. (Ebusco or the Company) is now authorized to issue new shares, for a period of 18 months following the date of the EGM, i.e. until and including 18 February 2027, up to a maximum of the authorized share capital of the company as of the date of the EGM.

    On 24 February 2025 Ebusco entered into three loan agreements (the February Loans), two of which were convertible into ordinary shares in the capital of the Company at the election of the loan holders:
    a €10m convertible loan agreement with Green Innovation International Co. Ltd (Green Innovation);
    a €2m convertible loan agreement with De Engh B.V. (De Engh); and
    a €10m loan agreement with CVI Investments, Inc., an entity managed by Heights Capital Management, Inc. (Heights).
    Green Innovation, De Engh and Heights together are referred to as the February Loan Holders.
    Green Innovation and De Engh agreed an option to convert their full amounts of the February Loans plus the fee at their election into ordinary shares in the capital of the Company, subject to approval from the Company’s shareholders, at any time at either (i) a conversion price of €0.50 or (ii) a conversion price that is equal to the closing share price of Ebusco on the day that is five (5) business days before either Green Innovation or De Engh elects to convert. The February Loans were required to be fully repaid by the Company by 15 August 2025, including €2.2m in fees (in aggregate).

    On 7 July 2025, the Company announced a restructuring of the February Loans, but also the restructuring of the Company’s letters of credit and bank guarantee facilities that were provided by ING Bank N.V. and Coöperatieve Rabobank U.A (the Bank Loans).

    Restructuring of the February Loans

    As part of the restructuring of the February Loans, it was agreed that the loan of Heights would also be convertible into ordinary shares in the capital of the Company, at the same terms as the loans of Green Innovation and De Engh. As a consequence, the full amount of the loans, €22m and the corresponding interest of €2.2m, is convertible into ordinary shares in the capital of the Company against a conversion price of €0.3260, which is the lower of (i) €0.50 and (ii) the closing share price of the Company’s ordinary shares on the day that was five (5) business days before 19 August 2025. As a consequence, 74,233,128 new shares will be issued to the February Loan Holders today.

    Restructuring of the Bank Loans

    On 7 July 2025, the Company announced that Heights and Kabuto Technology Co., Ltd. (Kabuto) agreed to take over the full position of ING Bank N.V. and Coöperatieve Rabobank U.A., respectively, under the Bank Loans, subject to certain conditions. The Bank Loans were due on 14 August 2025 and have been transferred to Heights and Kabuto for amounts of approximately €4.6m and €8.2m, respectively (which combined equals approximately the €12.8m that was outstanding under the Bank Loans).

    Heights and Kabuto (jointly referred to as the Bank Loan Holders), had the option to convert their respective portions of the Bank Loans into ordinary shares in the capital of the Company on or after 19 August 2025 at a conversion price which is the lower of (i) €0.40 and (ii) a ten per cent discount to the 5-day volume-weighted average price prior to 19 August 2025. This conversion price has now been set at €0.3231.

    It was further agreed that Kabuto (or any of its affiliates or partners) could take over the Heights portion of the Bank Loans by no later than 14 August 2025, which would then convert into ordinary shares in the capital of the Company on 19 August 2025, on the same terms.
    In the event Heights and/or Kabuto (as the case may be) would decide not to convert their respective portions of the Bank Loans into ordinary shares in the capital of Company on 19 August 2025, the Bank Loans will be amended into convertible loan agreements with a conversion price as specified above. These convertible loan agreements will then have a maturity date of 19 August 2026.

    On 15 August 2025, Kabuto indicated to the Company that it will exercise its conversion option on 19 August 2025, at the conversion price of €0.3231. Consequently, 25,354,731 new shares will be issued to Kabuto.

    On 15 August 2025, Heights indicated to Ebusco that it will not exercise this option, meaning that its portion of the Bank Loans will not be converted into ordinary shares in Ebusco for now and will be amended into a convertible loan agreement with a maturity of 19 August 2026. Heights has the right to exercise its conversion option after 19 August 2025, subject to providing a conversion notice to Ebusco 10 business days prior to the actual conversion. Conversion will then take place at the same terms.

    Both Green Innovation and Kabuto have agreed to a lock-up in respect of the ordinary shares in Ebusco that will be issued to them under the conversions referred to above, for a period ending six months after 19 August 2025.

    Issuance of the New Shares and publication of an (Annex IX) Information Document

    Conversion under the February Loans and the Bank Loans (for Kabuto only) has now occurred and under this conversion 99,587,859 new Ebusco shares will be issued today, 19 August 2025 (the New Shares). The New Shares are expected to be admitted to listing and trading on Thursday, 21 August 2025.

    In connection with the admission of the New Shares, Ebusco has prepared an Information Document in accordance with article 1(5)(ba)(iii) and Annex IX of Regulation 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC, as amended (the Prospectus Regulation). The Information Document is available via the following link: www.ebusco.com/wp-content/uploads/Ebu...
    The Information Document was filed with the Dutch Authority for the Financial Markets (the AFM) on 19 August 2025 (before market opening). The Information Document does not constitute a prospectus within the meaning of the Prospectus Regulation and has not been subject to the scrutiny and approval of the AFM, as competent authority.

    This press release contains inside information within the meaning of Article 7(1) of the European Market Abuse Regulation (MAR). This press release was distributed at 7:30 on 19 August
8.098 Posts
Pagina: «« 1 ... 337 338 339 340 341 ... 405 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.669
AB InBev 2 5.612
Abionyx Pharma 2 29
Ablynx 43 13.357
ABN AMRO 1.582 54.631
ABO-Group 1 27
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 12.127
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 203
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 18.456
Aedifica 3 1.032
Aegon 3.258 324.220
AFC Ajax 538 7.131
Affimed NV 2 6.358
ageas 5.844 109.970
Agfa-Gevaert 14 2.109
Ahold 3.541 74.529
Air France - KLM 1.025 35.878
AIRBUS 1 13
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.225
Alfen 17 28.874
Allfunds Group 4 1.704
Almunda Professionals (vh Novisource) 651 4.279
Alpha Pro Tech 1 17
Alphabet Inc. 1 466
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.487 114.840
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.856 250.598
AMG 972 138.912
AMS 3 73
Amsterdam Commodities 306 6.898
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 552
Antonov 22.632 153.607
Aperam 92 15.581
Apollo Alternative Assets 1 17
Apple 5 408
Arcadis 253 9.368
Arcelor Mittal 2.042 322.049
Archos 1 1
Arcona Property Fund 1 304
arGEN-X 17 11.443
Aroundtown SA 1 251
Arrowhead Research 5 9.853
Ascencio 1 38
ASIT biotech 2 697
ASMI 4.108 40.698
ASML 1.768 126.973
ASR Nederland 21 4.599
ATAI Life Sciences 1 7
Atenor Group 1 549
Athlon Group 121 176
Atos 3 3.099
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 34 17.255
Axsome Therapeutics 1 177
Azelis Group 2 139
Azerion 7 3.778